Status:
COMPLETED
Establishing an Inflammatory Breast Cancer Registry
Lead Sponsor:
National Cancer Institute (NCI)
Collaborating Sponsors:
United States Department of Defense
Conditions:
Inflammatory Breast Cancer
Eligibility:
FEMALE
18+ years
Brief Summary
Inflammatory breast carcinoma (IBC) is an extremely rare, aggressive form of breast cancer that disproportionately impacts young women. IBC often affects the skin of the breast, as well as the breast ...
Detailed Description
Inflammatory breast carcinoma (IBC) is an extremely rare, aggressive form of breast carcinoma that disproportionately affects young women. Clinical features of IBC include warmth, redness, edema, skin...
Eligibility Criteria
Inclusion
- Patients will be recruited from collaborating institutions throughout the US and through the IBC research foundation (established by patient advocate, Mr. Owen Johnson), which maintains a website and a research e-mail list. The goal is to recruit approximately 300 volunteers, at least 18 years of age or older.
Exclusion
Key Trial Info
Start Date :
June 1 2003
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
164 Patients enrolled
Trial Details
Trial ID
NCT00340158
Start Date
June 1 2003
Last Update
April 23 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Cancer Institute (NCI), 9000 Rockville Pike
Bethesda, Maryland, United States, 20892